HomeNMRA • NASDAQ
Neumora Therapeutics Inc
add
$0.68
5.31%
After Hours:(2.99%)+0.020
$0.70
Closed: May 23, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 70.94M | 18.08% |
Net income | -67.99M | -26.57% |
Net profit margin | — | — |
Earnings per share | -0.42 | -23.53% |
EBITDA | -70.78M | -18.13% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 249.35M | -41.01% |
Total assets | 256.75M | -42.97% |
Total liabilities | 28.38M | 10.58% |
Total equity | 228.36M | — |
Shares outstanding | 161.75M | — |
Price to book | 0.51 | — |
Return on assets | -61.82% | — |
Return on capital | -68.44% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -67.99M | -26.57% |
Cash from operations | -59.45M | -38.40% |
Cash from investing | 44.16M | 129.44% |
Cash from financing | — | — |
Net change in cash | -15.29M | 92.00% |
Free cash flow | -34.48M | -26.86% |
Previous close
$0.72
Day range
$0.66 - $0.74
Year range
$0.61 - $17.19
Market cap
109.60M USD
Avg Volume
921.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
103
